WebAssignee: BioClonetics Inventor: Joseph P. Cotropia Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) Patent number: 5777074 Abstract: A method for neutralizing HIV-1 is disclosed. A preferred embodiment utilizes a novel human monoclonal antibody that binds to a ...
Enzolytics Inc. Shares Current BioClonetics …
WebI had the pleasure of interviewing Charles Cotropia, CEO and co-founder of BioClonetics Immunotherapeutics, Inc. www.bioclonetics.com a Texas based biotech company. Thank you so much for joining us! Can you tell us a story about what brought you to this specific career path? My educational background is in Law and Aerospace Engineering. WebBioClonetics Immunotherapeutics is a biotechnology company with a proprietary methodology and expertise for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. BioClonetics Immunotherapeutics is a biotechnology company with a … BioClonetics’ technological methodologies have developed an effective, strong and … - Cano et al. cited the BioClonetics publications on (Clone 3) mAb, noting … BioClonetics’ technology addresses the HIV/AIDS pandemic with a proprietary … - Pendintg Patent coverage of small molecules (mini-peptides) for … Charles Cotropia, CEO, Juris Doctorate Degree Cornell Univ., B.S. Aerospace … Curing HIV – The BioClonetics Commitment Incorporating learning from leading … The Clone 3 Antibody secreted by the parent cell line created by the company … Projected Earnings from the BioClonetics’ passive immunotherapy have been … PUBLICATIONS SUPPORTING OUR TECHNOLOGY. Cheung, G., Cotropia, … fitted atlanta hat
Ashley Kingsley - President - Ashley Kingsley LLC LinkedIn
WebOct 19, 2024 · BioClonetics Immunotherapeutics, Inc. is a Dallas Texas biotech company with proprietary technology for producing fully human monoclonal antibodies (mAbs) … WebSep 16, 2024 · BioClonetics is in the final stage of development of a parent monoclonal antibody ("mAbs") (designated as Clone 3), which is non-toxic and has shown in initial … WebBioClonetics Incorporated. Jan 2014 - Present9 years 4 months. BioClonetics is a biotechnology company engaged in the discovery, … fitted atv covers